S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NASDAQ:CGNT

Cognyte Software - CGNT Stock Forecast, Price & News

$3.21
+0.06 (+1.90%)
(As of 03/28/2023 05:12 PM ET)
Add
Compare
Today's Range
$3.09
▼
$3.24
50-Day Range
$3.15
▼
$4.00
52-Week Range
$2.31
▼
$12.58
Volume
215,398 shs
Average Volume
389,503 shs
Market Capitalization
$216.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Cognyte Software MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
149.2% Upside
$8.00 Price Target
Short Interest
Healthy
1.39% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.83
Upright™ Environmental Score
News Sentiment
0.28mentions of Cognyte Software in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Computer And Technology Sector

294th out of 616 stocks

Prepackaged Software Industry

100th out of 213 stocks

See Top Rated MarketRank™ Stocks Here

CGNT stock logo

About Cognyte Software (NASDAQ:CGNT) Stock

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions. Its solutions are designed to support various use cases and support a range of users, including data analysts, investigation managers, and security operations center operators, as well as operational field teams. In addition, the company provides customer support, professional, and integration services. Its government customers include national, regional, and local government agencies; and enterprise customers consist of commercial and physical security customers. The company was incorporated in 2020 and is headquartered in Herzliya, Israel.

Receive CGNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter.

CGNT Stock News Headlines

March 21, 2023 | benzinga.com
COGNYTE INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Cognyte Investors of a Class Action Lawsuit and Upcoming Deadline
March 21, 2023 | benzinga.com
CGNT Investors Have Opportunity to Lead Cognyte Software Ltd. Securities Fraud Lawsuit
March 28, 2023 | Weiss Ratings (Ad)
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
March 20, 2023 | businesswire.com
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cognyte Software Ltd. (CGNT)
March 17, 2023 | businesswire.com
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cognyte Software Ltd. (CGNT)
March 16, 2023 | businesswire.com
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Cognyte Software Ltd. (CGNT) Investors
March 16, 2023 | technews.tmcnet.com
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cognyte Software Ltd. (CGNT) Investors
March 15, 2023 | businesswire.com
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Cognyte Software Ltd. (CGNT) Investors
March 28, 2023 | Stansberry Research (Ad)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
March 14, 2023 | businesswire.com
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cognyte Software Ltd. (CGNT) on Behalf of Investors
March 12, 2023 | benzinga.com
Cognyte Deadline Alert
March 9, 2023 | benzinga.com
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Cognyte Software Ltd. with Losses of $100,000 to Contact the Firm
March 9, 2023 | businesswire.com
Cognyte Software Ltd. (CGNT) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Cognyte Software Ltd.
March 8, 2023 | benzinga.com
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Cognyte Software Ltd. with Losses of $100,000 to Contact the Firm
March 8, 2023 | benzinga.com
Bronstein, Gewirtz & Grossman, LLC Notifies Cognyte Software Ltd. (CGNT) Investors of Class Action and to Actively Participate
March 7, 2023 | benzinga.com
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Cognyte Software Ltd. with Losses of $100,000 to Contact the Firm
March 4, 2023 | benzinga.com
ALERT: Investors in Cognyte Software Ltd with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – CGNT
March 3, 2023 | benzinga.com
Cognyte Shareholder Notice
March 3, 2023 | benzinga.com
Cognyte Shareholder Action Reminder
March 2, 2023 | benzinga.com
Lowey Dannenberg Notifies Cognyte Software Ltd. (NASDAQ: CGNT) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
January 15, 2023 | reuters.com
Israel's Cognyte won tender to sell intercept spyware to Myanmar before coup -documents
January 13, 2023 | markets.businessinsider.com
Needham Reaffirms Their Hold Rating on Cognyte Software (CGNT)
January 5, 2023 | finance.yahoo.com
Cognyte to Participate in the 25th Annual Needham Growth Conference
December 20, 2022 | finance.yahoo.com
Cognyte Software Reports Q3 Earnings Below Street View; Predicts Sequential Revenue Growth In Q4
December 19, 2022 | msn.com
A Preview Of Cognyte Software's Earnings
December 12, 2022 | finance.yahoo.com
Cognyte to Announce Third Quarter FY2023 Financial Results on December 20, 2022
November 14, 2022 | finance.yahoo.com
Cognyte Software Ltd. (NASDAQ:CGNT) institutional owners may be pleased with recent gains after 84% loss over the past year
See More Headlines
Receive CGNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter.

CGNT Company Calendar

Last Earnings
12/20/2021
Today
3/28/2023
Next Earnings (Estimated)
4/04/2023
Fiscal Year End
1/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
NASDAQ:CGNT
CUSIP
N/A
CIK
894237
Web
www.cogentixmedical.com
Phone
972-9962-2300
Fax
N/A
Employees
2,002
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.00
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+155.6%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,890,000.00
Net Margins
-27.34%
Pretax Margin
-21.70%
Return on Equity
-47.95%
Return on Assets
-22.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.33
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$474.04 million
Price / Sales
0.45
Cash Flow
$0.09 per share
Price / Cash Flow
34.83
Book Value
$4.45 per share
Price / Book
0.70

Miscellaneous

Outstanding Shares
67,480,000
Free Float
N/A
Market Cap
$211.21 million
Optionable
Not Optionable
Beta
1.35

Key Executives

  • Mr. Elad Sharon (Age 46)
    CEO & Director
  • Mr. David Abadi (Age 48)
    Chief Financial Officer
  • Mr. Ziv Levi (Age 53)
    Chief Legal Officer
  • Ms. Rini Karlin (Age 50)
    Chief People Officer
  • Mr. Miki Migdal (Age 61)
    Chief Bus. Officer
  • Mr. Sharon Chouli (Age 52)
    Chief Customer Officer
  • Mr. Avi Schechter (Age 56)
    Chief Revenue Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













CGNT Stock - Frequently Asked Questions

Should I buy or sell Cognyte Software stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognyte Software in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CGNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGNT, but not buy additional shares or sell existing shares.
View CGNT analyst ratings or view top-rated stocks.

What is Cognyte Software's stock price forecast for 2023?

5 equities research analysts have issued 12 month price objectives for Cognyte Software's stock. Their CGNT share price forecasts range from $3.00 to $12.00. On average, they anticipate the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 155.6% from the stock's current price.
View analysts price targets for CGNT or view top-rated stocks among Wall Street analysts.

How have CGNT shares performed in 2023?

Cognyte Software's stock was trading at $3.11 at the beginning of 2023. Since then, CGNT shares have increased by 0.6% and is now trading at $3.13.
View the best growth stocks for 2023 here.

Are investors shorting Cognyte Software?

Cognyte Software saw a increase in short interest in March. As of March 15th, there was short interest totaling 940,900 shares, an increase of 15.3% from the February 28th total of 816,100 shares. Based on an average trading volume of 524,700 shares, the short-interest ratio is currently 1.8 days. Approximately 1.4% of the shares of the company are short sold.
View Cognyte Software's Short Interest.

When is Cognyte Software's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 4th 2023.
View our CGNT earnings forecast.

How were Cognyte Software's earnings last quarter?

Cognyte Software Ltd. (NASDAQ:CGNT) posted its quarterly earnings results on Monday, December, 20th. The medical device company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.11. The medical device company had revenue of $118.70 million for the quarter, compared to analyst estimates of $114.83 million. Cognyte Software had a negative trailing twelve-month return on equity of 47.95% and a negative net margin of 27.34%. The firm's revenue was up 5.0% compared to the same quarter last year.

What ETFs hold Cognyte Software's stock?

ETFs with the largest weight of Cognyte Software (NASDAQ:CGNT) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL).ETFMG Prime Cyber Security ETF (HACK).

What other stocks do shareholders of Cognyte Software own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognyte Software investors own include EndoChoice (GI), Novavax (NVAX), Sorrento Therapeutics (SRNE), Exelixis (EXEL), Fc Global Realty (FCRE), Galectin Therapeutics (GALT), Immunomedics (IMMU), Iovance Biotherapeutics (IOVA), Neurocrine Biosciences (NBIX) and Nymox Pharmaceutical (NYMX).

What is Cognyte Software's stock symbol?

Cognyte Software trades on the NASDAQ under the ticker symbol "CGNT."

Who are Cognyte Software's major shareholders?

Cognyte Software's stock is owned by many different retail and institutional investors. Top institutional investors include Neuberger Berman Group LLC (6.49%), American Capital Management Inc. (6.00%), Legal & General Group Plc (5.57%), Senvest Management LLC (4.56%), William Blair Investment Management LLC (4.38%) and Arrowstreet Capital Limited Partnership (1.33%).
View institutional ownership trends.

How do I buy shares of Cognyte Software?

Shares of CGNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cognyte Software's stock price today?

One share of CGNT stock can currently be purchased for approximately $3.13.

How much money does Cognyte Software make?

Cognyte Software (NASDAQ:CGNT) has a market capitalization of $211.21 million and generates $474.04 million in revenue each year. The medical device company earns $-14,890,000.00 in net income (profit) each year or ($1.48) on an earnings per share basis.

How many employees does Cognyte Software have?

The company employs 2,002 workers across the globe.

How can I contact Cognyte Software?

Cognyte Software's mailing address is 5420 FELTL ROAD, MINNETONKA MN, 55343. The official website for the company is www.cogentixmedical.com. The medical device company can be reached via phone at 972-9962-2300 or via email at ir@cogentixmedical.com.

This page (NASDAQ:CGNT) was last updated on 3/28/2023 by MarketBeat.com Staff